WallStSmart
INO

Inovio Pharmaceuticals Inc

NASDAQ: INO · HEALTHCARE · BIOTECHNOLOGY

$1.12
+0.00% today

Updated 2026-04-30

Market cap
$95.46M
P/E ratio
P/S ratio
1,460.95x
EPS (TTM)
$-1.81
Dividend yield
52W range
$1 – $3
Volume
1.8M

Inovio Pharmaceuticals Inc (INO) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$3.47M$4.81M$2.10M$9.12M$6.14M$9.80M$4.12M$13.47M$10.46M$40.57M$35.37M$42.22M$30.48M$4.11M$7.41M$1.77M$10.26M$832010.00$217756.00$65343.00
Revenue growth (YoY)+38.6%-56.4%+334.8%-32.6%+59.4%-58.0%+227.0%-22.4%+288.0%-12.8%+19.4%-27.8%-86.5%+80.2%-76.1%+478.2%-91.9%-73.8%-70.0%
Cost of revenue$225000.00$19.36M$14.83M$20.12M$23.18M$29.98M$26.74M$32.88M$48.35M$57.79M$88.71M$98.57M$95.26M$88.02M$94.25M$4.73M$5.50M$3.50M$3.13M$2.99M
Gross profit$3.24M$4.81M$2.10M$9.12M$6.14M$9.80M$4.12M$13.47M$10.46M$40.57M$35.37M$42.22M$30.48M$4.11M$7.41M$1.77M$10.26M$832010.00$-2.91M$65343.00
Gross margin93.5%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%-1337.4%100.0%
R&D$8.51M$9.63M$5.75M$9.41M$13.26M$20.03M$17.98M$21.37M$34.10M$57.79M$88.71M$98.57M$95.26M$88.02M$94.25M$249.24M$187.65M$86.68M$75.62M$54.21M
SG&A$8.08M$11.08M$10.01M$13.67M$12.11M$11.99M$10.78M$13.64M$15.86M$18.06M$23.89M$28.29M$29.32M$27.20M$37.25M$53.75M$90.19M$47.58M$37.00B$32.68M
Operating income$-13.35M$-15.90M$-13.66M$-13.96M$-19.22M$-21.64M$-23.49M$-19.54M$-39.50M$-34.28M$-76.24M$-83.64M$-94.09M$-111.11M$-124.08M$-301.22M$-267.57M$-143.94M$-112.40M$-86.82M
Operating margin-384.8%-330.7%-651.1%-153.0%-312.8%-220.9%-570.4%-145.1%-377.7%-84.5%-215.5%-198.1%-308.7%-2702.1%-1674.2%-16972.3%-2607.4%-17300.3%-51616.9%-132871.3%
EBITDA$-12.43M$-10.19M$-11.97M$-13.96M$-17.11M$-21.64M$-22.65M$-19.45M$-37.93M$-33.37M$-74.15M$-84.74M$-89.80M$-107.34M$-149.56M$-296.56M$-270.90M$-130.39M$-103.95M$-81.96M
EBITDA margin-358.5%-211.9%-570.8%-153.0%-278.5%-220.9%-549.9%-144.4%-362.7%-82.2%-209.7%-200.7%-294.6%-2610.6%-2018.0%-16709.7%-2639.8%-15671.8%-47735.2%-125425.9%
EBIT$-13.35M$-11.14M$-12.97M$-15.63M$-19.22M$-23.65M$-24.64M$-21.54M$-39.50M$-35.28M$-77.24M$-88.21M$-94.80M$-112.86M$-154.19M$-301.29M$-276.40M$-133.89M$-107.08M$-84.95M
Interest expense$0.00$3.42M$49006.00$10.50M$1.51M$34285.00$4.93M$88.17M$3.36M$5.18M$139249.00$25933.00$346086.00$7.95M$8.70M$1.94M$1.25M$1.22M$177833.00$0.00
Income tax$-867070.00$-8.12M$-741848.00$11.71M$-4.08M$-16.28M$-8.11M$88.12M$-3.72M$-2.10M$-4.62M$1.76M$2.17M$-257335.00$52.20M$434387.00$2.17M$2.00$-107.15B
Effective tax rate6.5%42.0%5.4%-92.2%18.8%51.6%29.2%398.9%9.3%6.7%5.9%-2.0%-2.3%0.2%-45.7%-0.1%-0.8%-0.0%99.9%0.0%
Net income$-12.48M$-11.20M$-12.97M$-24.41M$-17.61M$-15.25M$-19.67M$-66.03M$-36.12M$-29.19M$-73.74M$-88.21M$-96.97M$-119.36M$-166.41M$-303.66M$-279.82M$-135.12M$-107.25M$-84.95M
Net income growth (YoY)+10.2%-15.7%-88.3%+27.8%+13.4%-29.0%-235.7%+45.3%+19.2%-152.6%-19.6%-9.9%-23.1%-39.4%-82.5%+7.9%+51.7%+20.6%+20.8%
Profit margin-359.8%-233.1%-618.1%-267.7%-286.6%-155.7%-477.6%-490.3%-345.4%-71.9%-208.5%-208.9%-318.1%-2902.8%-2245.4%-17109.9%-2726.7%-16239.9%-49254.3%-130000.0%